The Path To Anal Cancer Prevention: Where We Are And Where We’re Going

Joel Palefsky, MD, CM, F.R.C.P.(C)
Professor of Medicine, Division of Infectious Diseases
University of California, San Francisco

CME VIDEOTop of page

Learning Objectives:Top of page

At the completion of this educational session, participants should be able to:
  • Understand the epidemiology of anal cancer in the post-ART era.
  • Understand current approaches to anal cancer screening and their limitations.
  • Understand the role of HPV vaccination in anal cancer prevention.

About the Presenter:Top of page

Joel Palefsky is a Professor of Medicine at the University of California San Francisco School of Medicine, and an expert on the molecular biology, treatment, pathogenesis and natural history of anogenital human papillomavirus infections, particularly in the setting of HIV infection. He is the Director of the world's first clinic devoted to prevention of anal cancer, the Anal Neoplasia Clinic at the UCSF Cancer Center, and chair of the HPV Working Group of the U.S. National Cancer Institute-supported AIDS Malignancy Consortium. He is the founder of the newly established International Anal Neoplasia Society ( is the president-elect of the International Papillomavirus Society.

How To Get CMETop of page

To obtain CME credit for this and other PRN programs, please visit the PRN Video Channel at the Clinical Education Initiative (CEI) web site PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.

You must be logged in to post a comment. Login | Register